Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great biotech stocks to buy as spring approaches.
News & Analysis: Albany Molecular Research
Is now the perfect time for value investors to go bargain hunting in biotech?
These value stocks may be down, but they're far from out!
These three biotech companies may benefit if short sellers reverse course.
AMRI to acquire API manufacturer Cedarburg Pharmaceuticals for $41M.
Albany Molecular Research, Rockwell Medical, and Celgene could all make health care headlines this morning. Here’s why.
Albany Molecular Research shares sink after receiving a downgrade. Find out if this dip is warranted.
For the second time in a week Albany Molecular shares retreat. But this time it's for a very good reason.
Despite solid quarterly earnings results, Albany Molecular gets walloped for an all-too-common reason.
Don't just ask, "How much inventory?" Ask, "What kind?"